Today, URCH Publishing launches a comprehensive new report covering the distribution of medicines in the United States. “Pharmaceutical Distribution in the US - Current and Future Perspectives” shows how the US pharmaceutical wholesale sector has witnessed a rapid wave of consolidation to reach its current concentrated form dominated by three major full-line companies, namely Cardinal Health Inc., McKesson Corporation and AmerisourceBergen Corporation. Known collectively as the ‘Big Three’, these companies now account for between 90% and 95% of revenue within the sector.
Over 100 buyouts have taken place since 1980, and at least 57 have occurred over the past decade, but despite their dominance of the market the Big Three continue to look for further acquisitions, and market conditions favour a trend towards further consolidation, notes the report. However, the dominance of the Big Three has persuaded the Federal Trade Commission to re-examine their activities. Although there is no evidence of any gross violations, there is the potential for the market to be distorted as a result of the activities of these companies.
www.businesswire.com
Pharmaceutical Process Equipment
